Get the Stockscreener App
22.97
0.13%
-0.03
After Hours:
22.97
Fulgent Genetics Inc stock is traded at $22.97, with a volume of 268.95K.
It is down -0.13% in the last 24 hours and down -18.43% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$23.00
Open:
$23.14
24h Volume:
268.95K
Relative Volume:
1.03
Market Cap:
$710.06M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-4.1916
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
-3.12%
1M Performance:
-18.43%
6M Performance:
+9.33%
1Y Performance:
+41.62%
1-Day Range:
$22.39
$23.49
1-Week Range:
$22.39
$23.94
52-Week Range:
$14.76
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
22.97 | 710.99M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Upgrade | UBS | Neutral → Buy |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - Business Wire
Fulgent Genetics (NASDAQ:FLGT) Cut to Hold at Zacks Research - Defense World
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Zacks Research - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) versus Privia Health Group (NASDAQ:PRVA) Critical Contrast - Defense World
What’s the analyst consensus on Fulgent Genetics Inc.2025 Technical Patterns & Weekly Top Gainers Alerts - mfd.ru
FLGT to acquire Bako & StrataDx assets to expand pathology platform - MSN
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
(FLGT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Is Fulgent Genetics (NASDAQ:FLGT) A Risky Investment? - 富途牛牛
What Does The Institutional Ownership Tell Us About Fulgent Genetics? - simplywall.st
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock - Seeking Alpha
Breakout Move: Is Fulgent Genetics Inc a momentum stockMarket Performance Report & Accurate Intraday Trading Signals - baoquankhu1.vn
(FLGT) Risk Channels and Responsive Allocation - Stock Traders Daily
Market Review: What is the long term forecast for Fulgent Genetics Inc stock2025 Earnings Surprises & Low Risk Entry Point Tips - baoquankhu1.vn
Published on: 2026-01-19 16:33:56 - baoquankhu1.vn
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Buyout Rumor: Why Fulgent Genetics Inc stock remains undervaluedWatch List & Fast Entry and Exit Trade Plans - Bộ Nội Vụ
Why Fulgent Genetics Inc stock remains undervalued2025 Key Highlights & Community Consensus Trade Alerts - Bộ Nội Vụ
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Analysis Recap: Is ESEA stock a falling knife or bargain buy2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
Fulgent Will Acquire Two Laboratories - labusinessjournal.com
(FLGT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Will Fulgent Genetics Inc. stock continue dividend increasesEarnings Miss & Reliable Intraday Trade Plans - Улправда
How to contact the Daily Bulletin - FinancialContent
Will Fulgent Genetics Inc. stock maintain dividend yieldBreakout Watch & Smart Money Movement Alerts - ulpravda.ru
Fulgent Genetics, Inc.Common Stock (NQ: FLGT - FinancialContent
How strong is Fulgent Genetics Inc. stock revenue growthCPI Data & Low Risk High Win Rate Picks - ulpravda.ru
Is Fulgent Genetics Inc. (7F0) stock cheap by valuation metrics2025 Bull vs Bear & Long-Term Growth Portfolio Plans - ulpravda.ru
Aug Weekly: Is Fulgent Genetics Inc. (7F0) stock cheap by valuation metricsTrade Entry Report & Free Technical Pattern Based Buy Signals - ulpravda.ru
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 6.6% Over the Past Week - 富途牛牛
Is Fulgent Genetics Inc. (7F0) stock a fit for income portfoliosWeekly Trend Summary & Weekly Watchlist for Hot Stocks - ulpravda.ru
Health Check: How Prudently Does Fulgent Genetics (NASDAQ:FLGT) Use Debt? - simplywall.st
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - MarketScreener
Fulgent Genetics (NASDAQ:FLGT) Stock Price Up 7.3%Time to Buy? - MarketBeat
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates - MSN
How Fulgent Genetics Inc. stock performs in stagflation2026 world cup usa national team quarterfinals defensive leaders high defensive line match prediction breakdown - Улправда
Fulgent Genetics (NASDAQ:FLGT) vs. Mitesco (OTCMKTS:MITI) Critical Analysis - Defense World
Liquidity Mapping Around (FLGT) Price Events - Stock Traders Daily
Squarepoint Ops LLC Cuts Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform - Finviz
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics to acquire StrataDx and selected assets of Bako Diagnostics - Medical Buyer
Fulgent Genetics to acquire select assets of Bako Diagnostics and StrataDx for $55.5m - pehub.com
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx - Yahoo Finance
Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX - Legal Desire Media and Insights
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx - citybiz
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million - Investing.com Nigeria
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million By Investing.com - Investing.com South Africa
Fulgent Genetics (FLGT) to Acquire Assets from Bako Diagnostics and StrataDx - GuruFocus
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million - MarketScreener
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):